Stereotypies and tardive dyskinesia: abnormal movements in autistic children. 1990

M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
Department of Psychiatry, New York University Medical Center, NY.

Baseline stereotypic movements in 224 autistic children were studied as well as their relationship to certain demographic variables and measures of overall symptomatology and severity of illness. Prediction of haloperidol-related dyskinesias with measures of stereotypies and demographic variables was also attempted. Stereotypies were present in at least mild form in most children, with most showing moderate severity. Most stereotypies were in the orofacial area. I.Q. was found to be negatively related to stereotypies. Furthermore, across methods of assessment, severity and frequency of stereotypies were found to be positively related to overall symptomatology and severity of illness. No significant predictors of development of dyskinesias were found.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001321 Autistic Disorder A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V) Autism, Infantile,Kanner's Syndrome,Autism,Autism, Early Infantile,Disorder, Autistic,Disorders, Autistic,Early Infantile Autism,Infantile Autism,Infantile Autism, Early,Kanner Syndrome,Kanners Syndrome
D013239 Stereotyped Behavior Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. Behavior, Stereotyped,Behaviors, Stereotyped,Stereotyped Behaviors

Related Publications

M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
December 1981, The British journal of psychiatry : the journal of mental science,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
September 1978, The British journal of psychiatry : the journal of mental science,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
October 1988, Acta psychiatrica Scandinavica,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
January 1988, Psychopharmacology bulletin,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
July 1978, The American journal of psychiatry,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
February 1998, Journal of autism and developmental disorders,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
January 1985, L'Encephale,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
April 1990, Revista de enfermeria (Barcelona, Spain),
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
December 2018, The primary care companion for CNS disorders,
M Campbell, and J J Locascio, and M C Choroco, and E K Spencer, and R P Malone, and V Kafantaris, and J E Overall
April 2001, Human psychopharmacology,
Copied contents to your clipboard!